| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| BIM.PA - BioMerieux | HOLD | 0 @ EUR 118.8 | EUR 0 | The current share valuation price of BIM.PA based on adjusted close was EUR 118.8. The average price that BIM.PA shares were previous bought at was EUR 110.633. The current market price is 7.4% higher than average price they were purchased at. The value of the holding in BIM.PA has fallen by EUR 11,540 (USD $13,251) compared to the previous valuation of BioMerieux |
| RO.SW - | HOLD | 0 @ CHF 292.173 | CHF 0 | The current share valuation price of RO.SW based on adjusted close was CHF 292.173. The average price that RO.SW shares were previous bought at was CHF 302.302. The current market price is -3.4% lower than average price they were purchased at. The value of the holding in RO.SW has fallen by CHF 52,582 (USD $64,370) compared to the previous valuation of |
| FME.DE - Fresenius Medical Care AG | HOLD | 0 @ EUR 46.63 | EUR 0 | The current share valuation price of FME.DE based on adjusted close was EUR 46.63. The average price that FME.DE shares were previous bought at was EUR 46.8565. The current market price is -0.5% lower than average price they were purchased at. The value of the holding in FME.DE has fallen by EUR 56,670 (USD $65,072) compared to the previous valuation of Fresenius Medical Care AG |
| ERF.PA - Eurofins Scientific SE | HOLD | 0 @ EUR 60.5 | EUR 0 | The current share valuation price of ERF.PA based on adjusted close was EUR 60.5. The average price that ERF.PA shares were previous bought at was EUR 51.0554. The current market price is 18.5% higher than average price they were purchased at. The value of the holding in ERF.PA has fallen by EUR 6,567 (USD $7,541) compared to the previous valuation of Eurofins Scientific SE |
| SRT3.DE - Sartorius AG | HOLD | 0 @ EUR 209.5 | EUR 0 | The current share valuation price of SRT3.DE based on adjusted close was EUR 209.5. The average price that SRT3.DE shares were previous bought at was EUR 220.626. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in SRT3.DE has increased by EUR 1,035 (USD $1,188) compared to the previous valuation of Sartorius AG however if the holding was sold on 2025-06-18 this would crystalise an overall loss. |
| SOBI.ST - | HOLD | 0 @ SEK 25.468 | SEK 0 | The current share valuation price of SOBI.ST based on adjusted close was SEK 25.468. The average price that SOBI.ST shares were previous bought at was SEK 26.9812. The current market price is -5.6% lower than average price they were purchased at. The value of the holding in SOBI.ST has fallen by SEK 11,474 (USD $1,202) compared to the previous valuation of |
| GALD.SW - | HOLD | 0 @ CHF 117.613 | CHF 0 | The current share valuation price of GALD.SW based on adjusted close was CHF 117.613. The average price that GALD.SW shares were previous bought at was CHF 104.269. The current market price is 12.8% higher than average price they were purchased at. The value of the holding in GALD.SW has increased by CHF 124,169 (USD $152,006) compared to the previous valuation of however if the holding was sold on 2025-06-18 this would crystalise an overall loss. |
| DIM.PA - Sartorius Stedim Biotech | HOLD | 0 @ EUR 197.05 | EUR 0 | The current share valuation price of DIM.PA based on adjusted close was EUR 197.05. The average price that DIM.PA shares were previous bought at was EUR 190.197. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in DIM.PA has fallen by EUR 8,648 (USD $9,930) compared to the previous valuation of Sartorius Stedim Biotech |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | HOLD | 0 @ EUR 53.5 | EUR 0 | The current share valuation price of REC.MI based on adjusted close was EUR 53.5. The average price that REC.MI shares were previous bought at was EUR 52.548. The current market price is 1.8% higher than average price they were purchased at. The value of the holding in REC.MI has fallen by EUR 33,983 (USD $39,021) compared to the previous valuation of Recordati Industria Chimica e Farmaceutica SpA |
| ORNBV.HE - Orion Oyj | HOLD | 0 @ EUR 63.15 | EUR 0 | The current share valuation price of ORNBV.HE based on adjusted close was EUR 63.15. The average price that ORNBV.HE shares were previous bought at was EUR 50.7131. The current market price is 24.5% higher than average price they were purchased at. The value of the holding in ORNBV.HE has increased by EUR 4,289 (USD $4,925) compared to the previous valuation of Orion Oyj however if the holding was sold on 2025-06-18 this would crystalise an overall loss. |
| SN.L - Smith & Nephew PLC | HOLD | 0 @ GBP 12.4714 | GBP 0 | The current share valuation price of SN.L based on adjusted close was GBP 12.4714. The average price that SN.L shares were previous bought at was GBP 12.775. The current market price is -2.4% lower than average price they were purchased at. The value of the holding in SN.L has fallen by GBP 52,614 (USD $70,661) compared to the previous valuation of Smith & Nephew PLC |
| IPN.PA - Ipsen SA | HOLD | 0 @ EUR 101.7 | EUR 0 | The current share valuation price of IPN.PA based on adjusted close was EUR 101.7. The average price that IPN.PA shares were previous bought at was EUR 107.092. The current market price is -5.0% lower than average price they were purchased at. The value of the holding in IPN.PA has fallen by EUR 14,837 (USD $17,037) compared to the previous valuation of Ipsen SA |
| HIK.L - | HOLD | 0 @ GBP 24.1481 | GBP 0 | The current share valuation price of HIK.L based on adjusted close was GBP 24.1481. The average price that HIK.L shares were previous bought at was GBP 24.4976. The current market price is -1.4% lower than average price they were purchased at. The value of the holding in HIK.L has fallen by GBP 15,626 (USD $20,986) compared to the previous valuation of |
| DEMANT.CO - | HOLD | 0 @ DKK 36.8936 | DKK 0 | The current share valuation price of DEMANT.CO based on adjusted close was DKK 36.8936. The average price that DEMANT.CO shares were previous bought at was DKK 34.1992. The current market price is 7.9% higher than average price they were purchased at. The value of the holding in DEMANT.CO has fallen by DKK 6,485 (USD $998) compared to the previous valuation of |
| GRF.MC - Grifols SA | HOLD | 0 @ EUR 10.375 | EUR 0 | The current share valuation price of GRF.MC based on adjusted close was EUR 10.375. The average price that GRF.MC shares were previous bought at was EUR 10.2434. The current market price is 1.3% higher than average price they were purchased at. The value of the holding in GRF.MC has fallen by EUR 15,362 (USD $17,640) compared to the previous valuation of Grifols SA |
| DIA.MI - DiaSorin SpA | HOLD | 0 @ EUR 93.58 | EUR 0 | The current share valuation price of DIA.MI based on adjusted close was EUR 93.58. The average price that DIA.MI shares were previous bought at was EUR 68.5775. The current market price is 36.5% higher than average price they were purchased at. The value of the holding in DIA.MI has increased by EUR 1,257 (USD $1,443) compared to the previous valuation of DiaSorin SpA however if the holding was sold on 2025-06-18 this would crystalise an overall loss. |
| NOVO-B.CO - Novo Nordisk A/S | HOLD | 0 @ DKK 64.6844 | DKK 0 | The current share valuation price of NOVO-B.CO based on adjusted close was DKK 64.6844. The average price that NOVO-B.CO shares were previous bought at was DKK 65.9517. The current market price is -1.9% lower than average price they were purchased at. The value of the holding in NOVO-B.CO has fallen by DKK 949,159 (USD $146,138) compared to the previous valuation of Novo Nordisk A/S |
| COLO-B.CO - | HOLD | 0 @ DKK 80.812 | DKK 0 | The current share valuation price of COLO-B.CO based on adjusted close was DKK 80.812. The average price that COLO-B.CO shares were previous bought at was DKK 92.5737. The current market price is -12.7% lower than average price they were purchased at. The value of the holding in COLO-B.CO has fallen by DKK 88,886 (USD $13,685) compared to the previous valuation of |
| QIA.DE - QIAGEN NV | HOLD | 0 @ EUR 40.575 | EUR 0 | The current share valuation price of QIA.DE based on adjusted close was EUR 40.575. The average price that QIA.DE shares were previous bought at was EUR 37.624. The current market price is 7.8% higher than average price they were purchased at. The value of the holding in QIA.DE has fallen by EUR 2,564 (USD $2,944) compared to the previous valuation of QIAGEN NV |
| HLN.L - Haleon PLC | HOLD | 0 @ GBP 4.49182 | GBP 0 | The current share valuation price of HLN.L based on adjusted close was GBP 4.49182. The average price that HLN.L shares were previous bought at was GBP 4.70903. The current market price is -4.6% lower than average price they were purchased at. The value of the holding in HLN.L has fallen by GBP 76,275 (USD $102,438) compared to the previous valuation of Haleon PLC |
| BAYN.DE - Bayer AG | HOLD | 0 @ EUR 27.205 | EUR 0 | The current share valuation price of BAYN.DE based on adjusted close was EUR 27.205. The average price that BAYN.DE shares were previous bought at was EUR 21.9962. The current market price is 23.7% higher than average price they were purchased at. The value of the holding in BAYN.DE has increased by EUR 17,514 (USD $20,111) compared to the previous valuation of Bayer AG however if the holding was sold on 2025-06-18 this would crystalise an overall loss. |
| NOVN.SW - | HOLD | 0 @ CHF 100.901 | CHF 0 | The current share valuation price of NOVN.SW based on adjusted close was CHF 100.901. The average price that NOVN.SW shares were previous bought at was CHF 98.158. The current market price is 2.8% higher than average price they were purchased at. The value of the holding in NOVN.SW has fallen by CHF 563,355 (USD $689,651) compared to the previous valuation of |
| AZN.L - AstraZeneca PLC | HOLD | 0 @ GBP 123.288 | GBP 0 | The current share valuation price of AZN.L based on adjusted close was GBP 123.288. The average price that AZN.L shares were previous bought at was GBP 128.315. The current market price is -3.9% lower than average price they were purchased at. The value of the holding in AZN.L has fallen by GBP 1,042,320 (USD $1,399,839) compared to the previous valuation of AstraZeneca PLC |
| SAN.PA - Sanofi SA | HOLD | 0 @ EUR 82.81 | EUR 0 | The current share valuation price of SAN.PA based on adjusted close was EUR 82.81. The average price that SAN.PA shares were previous bought at was EUR 95.2663. The current market price is -13.1% lower than average price they were purchased at. The value of the holding in SAN.PA has fallen by EUR 897,280 (USD $1,030,314) compared to the previous valuation of Sanofi SA |
| GSK.L - GlaxoSmithKline PLC | HOLD | 0 @ GBP 16.9422 | GBP 0 | The current share valuation price of GSK.L based on adjusted close was GBP 16.9422. The average price that GSK.L shares were previous bought at was GBP 16.7885. The current market price is 0.9% higher than average price they were purchased at. The value of the holding in GSK.L has fallen by GBP 663,815 (USD $891,505) compared to the previous valuation of GlaxoSmithKline PLC |
| EL.PA - EssilorLuxottica SA | HOLD | 0 @ EUR 241.4 | EUR 0 | The current share valuation price of EL.PA based on adjusted close was EUR 241.4. The average price that EL.PA shares were previous bought at was EUR 248.822. The current market price is -3.0% lower than average price they were purchased at. The value of the holding in EL.PA has increased by EUR 106,038 (USD $121,760) compared to the previous valuation of EssilorLuxottica SA however if the holding was sold on 2025-06-18 this would crystalise an overall loss. |
| LONN.SW - | HOLD | 0 @ CHF 594.546 | CHF 0 | The current share valuation price of LONN.SW based on adjusted close was CHF 594.546. The average price that LONN.SW shares were previous bought at was CHF 584.866. The current market price is 1.7% higher than average price they were purchased at. The value of the holding in LONN.SW has fallen by CHF 24,594 (USD $30,108) compared to the previous valuation of |
| ALC.SW - | HOLD | 0 @ CHF 73.8401 | CHF 0 | The current share valuation price of ALC.SW based on adjusted close was CHF 73.8401. The average price that ALC.SW shares were previous bought at was CHF 81.3862. The current market price is -9.3% lower than average price they were purchased at. The value of the holding in ALC.SW has fallen by CHF 133,820 (USD $163,820) compared to the previous valuation of |
| ARGX.BR - Argenx SE | HOLD | 0 @ EUR 472.8 | EUR 0 | The current share valuation price of ARGX.BR based on adjusted close was EUR 472.8. The average price that ARGX.BR shares were previous bought at was EUR 551.897. The current market price is -14.3% lower than average price they were purchased at. EUR 0 (USD $0) compared to the previous valuation of Argenx SE |
| UCB.BR - UCB SA | HOLD | 0 @ EUR 155.15 | EUR 0 | The current share valuation price of UCB.BR based on adjusted close was EUR 155.15. The average price that UCB.BR shares were previous bought at was EUR 171.449. The current market price is -9.5% lower than average price they were purchased at. The value of the holding in UCB.BR has fallen by EUR 150,273 (USD $172,553) compared to the previous valuation of UCB SA |
| ROG.SW - | HOLD | 0 @ CHF 275.28 | CHF 0 | The current share valuation price of ROG.SW based on adjusted close was CHF 275.28. The average price that ROG.SW shares were previous bought at was CHF 285.605. The current market price is -3.6% lower than average price they were purchased at. The value of the holding in ROG.SW has fallen by CHF 823,487 (USD $1,008,100) compared to the previous valuation of |
| PHIA.AS - Koninklijke Philips NV | HOLD | 0 @ EUR 19.28 | EUR 0 | The current share valuation price of PHIA.AS based on adjusted close was EUR 19.28. The average price that PHIA.AS shares were previous bought at was EUR 22.709. The current market price is -15.1% lower than average price they were purchased at. The value of the holding in PHIA.AS has fallen by EUR 72,331 (USD $83,055) compared to the previous valuation of Koninklijke Philips NV |
| MRK.DE - Merck KGaA | HOLD | 0 @ EUR 109.7 | EUR 0 | The current share valuation price of MRK.DE based on adjusted close was EUR 109.7. The average price that MRK.DE shares were previous bought at was EUR 130.164. The current market price is -15.7% lower than average price they were purchased at. The value of the holding in MRK.DE has fallen by EUR 122,880 (USD $141,099) compared to the previous valuation of Merck KGaA |
| SDZ.SW - | HOLD | 0 @ CHF 46.1102 | CHF 0 | The current share valuation price of SDZ.SW based on adjusted close was CHF 46.1102. The average price that SDZ.SW shares were previous bought at was CHF 40.3939. The current market price is 14.2% higher than average price they were purchased at. The value of the holding in SDZ.SW has increased by CHF 167,824 (USD $205,448) compared to the previous valuation of however if the holding was sold on 2025-06-18 this would crystalise an overall loss. |
| SOON.SW - | HOLD | 0 @ CHF 262.425 | CHF 0 | The current share valuation price of SOON.SW based on adjusted close was CHF 262.425. The average price that SOON.SW shares were previous bought at was CHF 291.912. The current market price is -10.1% lower than average price they were purchased at. The value of the holding in SOON.SW has increased by CHF 26,296 (USD $32,191) compared to the previous valuation of however if the holding was sold on 2025-06-18 this would crystalise an overall loss. |
| SHL.DE - Siemens Healthineers AG | HOLD | 0 @ EUR 45.54 | EUR 0 | The current share valuation price of SHL.DE based on adjusted close was EUR 45.54. The average price that SHL.DE shares were previous bought at was EUR 48.2129. The current market price is -5.5% lower than average price they were purchased at. The value of the holding in SHL.DE has fallen by EUR 44,245 (USD $50,805) compared to the previous valuation of Siemens Healthineers AG |
| FRE.DE - Fresenius SE & Co KGaA | HOLD | 0 @ EUR 42.04 | EUR 0 | The current share valuation price of FRE.DE based on adjusted close was EUR 42.04. The average price that FRE.DE shares were previous bought at was EUR 37.9992. The current market price is 10.6% higher than average price they were purchased at. The value of the holding in FRE.DE has fallen by EUR 162,335 (USD $186,403) compared to the previous valuation of Fresenius SE & Co KGaA |
| GMAB.CO - | HOLD | 0 @ DKK 189.897 | DKK 0 | The current share valuation price of GMAB.CO based on adjusted close was DKK 189.897. The average price that GMAB.CO shares were previous bought at was DKK 190.425. The current market price is -0.3% lower than average price they were purchased at. The value of the holding in GMAB.CO has fallen by DKK 83,921 (USD $12,921) compared to the previous valuation of |
| STMN.SW - | HOLD | 0 @ CHF 109.91 | CHF 0 | The current share valuation price of STMN.SW based on adjusted close was CHF 109.91. The average price that STMN.SW shares were previous bought at was CHF 118.249. The current market price is -7.1% lower than average price they were purchased at. The value of the holding in STMN.SW has fallen by CHF 47,620 (USD $58,296) compared to the previous valuation of |